Pulmonary function testing during the COVID-19 pandemicin.
作者信息
Christopher Devasahayam Jesudas, Mohan B V Murali, Singla Rupak, Koul Parvaiz A
机构信息
Department of Pulmonary Medicine, Christian Medical College, Vellore, Tamil Nadu, India.
Department of Pulmonology and Internal Medicine, Narayana Health - Mazumdar Shaw Medical Centre, Narayana Health City, Bengaluru, Karnataka, India.
出版信息
Lung India. 2021 Mar;38(Supplement):S92-S96. doi: 10.4103/lungindia.lungindia_738_20.
Abstract
摘要
相似文献
1
Pulmonary function testing during the COVID-19 pandemicin.2019年冠状病毒病大流行期间的肺功能测试
Lung India. 2021 Mar;38(Supplement):S92-S96. doi: 10.4103/lungindia.lungindia_738_20.
2
[Expert consensus on pulmonary function testing during the epidemic of coronavirus disease 2019].《新型冠状病毒肺炎疫情期间肺功能检查专家共识》
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Apr 12;43(4):302-307. doi: 10.3760/cma.j.cn112147-20200225-00175.
3
Recommendations for pulmonary function laboratories in the COVID-19 era.COVID-19 时代肺功能实验室的建议。
Medicina (B Aires). 2021;81(2):229-240.
4
Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic.COVID-19 大流行期间与胺碘酮相关的过敏性肺炎病例报告。
Rev Cardiovasc Med. 2021 Mar 30;22(1):181-184. doi: 10.31083/j.rcm.2021.01.267.
5
[COVID-19: A Pneumological Point of View - Long-Term Sequelae of COVID-19 - Implications For Follow-up In Respiratory Medicine].[新型冠状病毒肺炎：从肺病学角度看——新型冠状病毒肺炎的长期后遗症——对呼吸医学随访的影响]
Dtsch Med Wochenschr. 2020 Jul;145(15):1086-1092. doi: 10.1055/a-1164-4040. Epub 2020 Jul 30.
6
[Postinflammatroy pulmonary fibrosis of COVID-19: the current status and perspective].[新型冠状病毒肺炎炎症后肺纤维化：现状与展望]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Sep 12;43(9):728-732. doi: 10.3760/cma.j.cn112147-20200317-00359.
7
Analysis of Chest CT Results of Coronavirus Disease 2019 (COVID-19) Patients at First Follow-Up.分析 2019 年冠状病毒病（COVID-19）患者首次随访时的胸部 CT 结果。
Can Respir J. 2020 Nov 1;2020:5328267. doi: 10.1155/2020/5328267. eCollection 2020.
8
Pulmonary function of patients with 2019 novel coronavirus induced-pneumonia: a retrospective cohort study.2019新型冠状病毒感染肺炎患者的肺功能：一项回顾性队列研究。
Ann Palliat Med. 2020 Sep;9(5):3447-3452. doi: 10.21037/apm-20-1688.
9
Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial.新冠肺炎恢复期继发肺纤维化患者采用中西医结合治疗的疗效：一项随机多中心试验。
Infect Dis Poverty. 2021 Mar 18;10(1):31. doi: 10.1186/s40249-021-00813-8.
10
Pericytes Within A Pulmonary Neurovascular Unit in Coronavirus Disease 2019 Elicited Pathological Changes.在 2019 年冠状病毒病中，肺神经血管单元中的周细胞引发病理性变化。
Curr Neurovasc Res. 2020;17(5):784-792. doi: 10.2174/1567202617666201222112639.
引用本文的文献
1
Management of chronic respiratory diseases during viral pandemics: A concise review of guidance and recommendations.病毒性大流行期间慢性呼吸道疾病的管理：指南与建议简要综述
J Family Med Prim Care. 2022 Nov;11(11):6633-6639. doi: 10.4103/jfmpc.jfmpc_974_21. Epub 2022 Dec 16.
2
Knowledge and awareness of chronic bronchitis and its oral manifestation among dental students and practitioners.牙科学生和从业者对慢性支气管炎及其口腔表现的认识和了解。
J Adv Pharm Technol Res. 2022 Dec;13(Suppl 2):S539-S544. doi: 10.4103/japtr.japtr_174_22. Epub 2022 Dec 30.
3
Pulmonary function testing during SARS-CoV-2: An ANZSRS/TSANZ position statement.SARS-CoV-2 期间的肺功能测试：ANZSRS/TSANZ 立场声明。
Respirology. 2022 Sep;27(9):688-719. doi: 10.1111/resp.14340. Epub 2022 Aug 10.
4
A low-cost pulmonary function test laboratory setup for infection control during COVID-19.一种用于在新冠疫情期间进行感染控制的低成本肺功能测试实验室设置。
Lung India. 2022 Jan-Feb;39(1):93-94. doi: 10.4103/lungindia.lungindia_578_21.
本文引用的文献
1
Lung function monitoring in the era of respiratory pandemics.呼吸道大流行时代的肺功能监测
Clin Physiol Funct Imaging. 2020 Sep;40(5):377-379. doi: 10.1111/cpf.12650. Epub 2020 Jun 29.
2
Rethinking respiratory function laboratories in the era of coronavirus disease 2019: Considerations for today and the day after.2019冠状病毒病时代对呼吸功能实验室的重新思考：当下与未来的考量
Ann Allergy Asthma Immunol. 2020 Aug;125(2):210-211. doi: 10.1016/j.anai.2020.05.021. Epub 2020 May 26.
3
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19).慢性阻塞性肺疾病与严重的2019冠状病毒病（COVID-19）相关。
Respir Med. 2020 Jun;167:105941. doi: 10.1016/j.rmed.2020.105941. Epub 2020 Mar 24.
4
Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19.湍流气体云与呼吸道病原体排放：对减少新冠病毒传播的潜在影响
JAMA. 2020 May 12;323(18):1837-1838. doi: 10.1001/jama.2020.4756.
5
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.与严重急性呼吸综合征冠状病毒1（SARS-CoV-1）相比，严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在气溶胶和表面的稳定性
N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.
6
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
7
Daily Peak Expiratory Flow Rate and Disease Instability in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者的每日呼气峰值流速与疾病不稳定性
Chronic Obstr Pulm Dis. 2015 Nov 11;3(1):398-405. doi: 10.15326/jcopdf.3.1.2015.0142.
8
Peak flow meter with a questionnaire and mini-spirometer to help detect asthma and COPD in real-life clinical practice: a cross-sectional study.峰流速仪结合问卷和迷你肺活量计有助于在真实临床实践中检测哮喘和 COPD：一项横断面研究。
NPJ Prim Care Respir Med. 2017 May 9;27(1):32. doi: 10.1038/s41533-017-0036-8.
9
Comparison of Three Screening Questionnaires for Chronic Obstructive Pulmonary Disease in the Primary Care.基层医疗中三种慢性阻塞性肺疾病筛查问卷的比较
Respiration. 2017;93(2):83-89. doi: 10.1159/000453586. Epub 2017 Jan 5.
10
Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study.日本普通人群中慢性阻塞性肺疾病人群筛查问卷与国际初级保健气道组问卷的比较：久山研究
Int J Chron Obstruct Pulmon Dis. 2016 Aug 16;11:1903-9. doi: 10.2147/COPD.S110429. eCollection 2016.
Zotero 插件